This project was completed by Intensity. Intensity joined Secretariat on February 1, 2023.
A generic drug company filed an Abbreviated New Drug Application (ANDA) seeking approval to sell a generic version of a branded sedative drug prior to the expiration of patents covering the branded drug. The generic drug company also filed paragraph IV certification, asserting that the patents covering the branded drug were invalid as obvious. In response, the branded drug company filed claims of patent infringement against the generic drug company.
Intensity performed an evaluation of the commercial success of the branded sedative drug and the patents-in-suit. Intensity determined whether the commercial performance of branded drug was attributable to the patents-in-suit or other economic factors, and whether such performance was commercially successful.
Intensity analyzed sales and economic profits of the branded drug. We evaluated those sales and profits in an appropriate economic context by defining a relevant market and comparing sales of the branded drug to relevant benchmarks.
Navigating ECCTA: A Guide for Organizations
Ben Boorer, writing for Enterprise Times, discusses the Economic Crime and Corporate Transparency Act (ECCTA), which comes into force on 1st September 2025. ECCTA will reshape the UK’s compliance landscape by, amongst other things, holding organisations accountable for fraud committed by employees, agents, and subsidiaries.
Google Damages Ruling Offers Lessons for Testifying Experts
In an article for Law360, Director Adam Rhoten explores the implications and significance of the recent en banc U.S. Court of Appeals for the Federal Circuit decision in EcoFactor Inc. v. Google LLC, a significant ruling that marks a shift toward stricter judicial scrutiny of expert testimony in patent cases.
Achieving Organic Growth for a Legal Nonprofit
In this article for Law 360, Secretariat Managing Directors and co-founders of Law Rocks Nick Child and Ted Scott reflect on their journey of founding the nonprofit, reflecting on the biggest challenges they faced, and how they balance this endeavor with their full-time careers.